Ratings Moves: MGM,...
Health Care: Drugs
Arena Pharmaceuticals Inc. (ARNA: NASDAQ)
$8.06 0.14 | 1.77%
05/23/13 - 04:00 PM ET
Portfolios with ARNA
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Under-$10 Moving Hig...
- UserMy Watch List
- Usermichelle
- User2012 picks 10/28/20121
- Usermine
- ContributorStocks Under-$10 Moving Hig...
- UserMy SP portfolio
- UserMyfuture
- ContributorStocks Under-$10 Setting Up...
Latest ARNA Headlines from TheStreet
- Happy Day for Arena Bulls, Bears As Belviq Launch Finally Arrives 05.07.13 | 11:05 am
- Arena Stock Gaps Down On Today's Open (ARNA) 05.03.13 | 09:05 am
- Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy 04.12.13 | 06:04 am
- Large Vivus Shareholder Seeks More Change 04.10.13 | 10:04 am
- Arena Bulls, Bears Endure Annoyingly Long Wait for Belviq Launch 04.10.13 | 09:04 am
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- Vivus Piles New Debt On Top Of Excuses 03.26.13 | 10:03 am
- Arena Pharmaceuticals Inc. (ARNA): Health Care's Featured Stock Of The Day 03.25.13 | 05:03 pm
- 2 Drug Stocks Under $10 To Pick As Favorites 03.25.13 | 02:03 pm
- Best And Worst FDA Drug Approval Stocks of 2013 03.12.13 | 08:03 am
Press Releases for ARNA
- Pill Economics - Research Report On Arena Pharmaceuticals, Inc. And Amgen, Inc. - PR Newswire 01.23.13 | 08:01 am
- Stock Alerts For Coca-Cola, Deere, News Corp., Arena Pharmaceuticals, And American Tower Released By InvestorsObserver - PR Newswire 06.28.12 | 09:06 am
- Arena Pharmaceuticals Investigated By Goldfarb Branham Law Firm LLP - Business Wire 10.08.10 | 09:10 am
- Girard Gibbs LLP Files Class Action Lawsuit Against Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) - Business Wire 09.29.10 | 05:09 pm
- Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Against Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) - Business Wire 09.28.10 | 02:09 pm
- Investor Notice: The Rosen Law Firm Announces Filing Of Securities Class Action Against Arena Pharmaceuticals, Inc. - ARNA - Business Wire 09.22.10 | 06:09 pm
- Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Arena Pharmaceuticals, Inc. - Business Wire 09.22.10 | 05:09 pm
- The Law Office Of Robbins Umeda LLP Announces An Investigation Of Arena Pharmaceuticals, Inc. - Business Wire 09.22.10 | 12:09 pm
Partner Headlines for ARNA
- 4 Healthcare Stock Stories Prescribed for Investors - Wall St. Cheat Sheet 04.01.13 | 05:04 am
- 4 Healthcare Stock Stories Prescribed for Investors - Wall St. Cheat Sheet 04.01.13 | 05:04 am
- Fannie Mae And Freddie Mac, Short-Term Trade Or Deep Value Investment? - Seeking Alpha 03.25.13 | 09:03 am
- A Look At 3 Obesity Stocks - Seeking Alpha 03.05.13 | 09:03 am
- Trius Therapeutics: New MSRA Treatment Could Bring Billions In Revenues - Seeking Alpha 03.05.13 | 09:03 am
- Pre-Market Earnings Report for March 4, 2013 : RIG, SSYS, TECD, ARNA, CEL, BYD, YGE, ALVR - NASDAQ 03.01.13 | 09:03 pm
- Arena's Recent Outperform Call And A Probability Weighted Valuation - Seeking Alpha 02.08.13 | 08:02 am
- Arena Must Wait For European Approval - Seeking Alpha 01.19.13 | 07:01 am
- Orexigen: The Best Bet In Obesity For 2013 - Seeking Alpha 12.17.12 | 09:12 am
- Arena Opening New Doors - Seeking Alpha 11.29.12 | 09:11 am
